Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Running, not enrolling · Phase 2
Conditions studied: Chronic Myelogenous Leukemia - Chronic Phase
In brief
This will be a multicenter Phase II open-label study of asciminib in CML-CP patients who have been previously treated with one prior ATP- binding site TKI with discontinuation due to treatment failure, warning or intolerance. (2L patient cohort). In addition, newly diagnosed CML-CP patients who may have received up to 4 weeks of prior TKI are included in a separate 1L patient cohort.
Key facts
- Study ID
- NCT05384587
- Run by
- Novartis Pharmaceuticals
- People needed
- 34
- Starts
- 2022-11-11
- Expected to finish
- 2027-10-17
- Last updated by the study team
- 2025-10-14
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Alaska Oncology and Hematology — Anchorage, Alaska, United States
- City of Hope Phoenix — Scottsdale, Arizona, United States
- USO Arizona Oncology — Tucson, Arizona, United States
- Onco Inst of Hope and Innovation — Cerritos, California, United States
- City of Hope National Medical — Duarte, California, United States
- UCSF Fresno Internal Medicine — Fresno, California, United States
- Virginia K Crosson Cancer Center — Fullerton, California, United States
- UCLA — Los Angeles, California, United States
- Alta Bates Summit Medical Center — Oakland, California, United States
- Lundquist Inst BioMed at Harbor — Torrance, California, United States
- Rocky Mountain Cancer Centers — Boulder, Colorado, United States
- Yale University School Of Medicine — New Haven, Connecticut, United States
- The Stamford Hospital — Stamford, Connecticut, United States
- Florida Cancer Specialists — Fort Myers, Florida, United States
- Baptist MD Anderson Cancer Center — Jacksonville, Florida, United States
- Florida Cancer Specialists-North — St. Petersburg, Florida, United States
- Florida Cancer Specialists East — Stuart, Florida, United States
- City Of Hope Atlanta — Atlanta, Georgia, United States
- Emory University School of Medicine Winship Cancer Institute — Atlanta, Georgia, United States
- Augusta University Georgia — Augusta, Georgia, United States
- Northwest Georgia Oncology Center — Marietta, Georgia, United States
- Franciscan Health Indianapolis — Indianapolis, Indiana, United States
- Investigative Clinicl Rsrch of Indi — Indianapolis, Indiana, United States
- Holden Comp Can Cent Quad Cities U — Iowa City, Iowa, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.